Dataset from A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study of DU-176b in Patients With NVAF Aged 80 Years or Older Who Are Ineligible for Available Oral Anticoagulation Therapy

The purpose of this study is to evaluate the efficacy and safety of edoxaban in patients with
non-valvular NVAF aged 80 years or older who are ineligible for available oral
anticoagulation therapy.

本研究旨在评估艾多沙班（edoxaban）对80岁及以上、无法接受现有口服抗凝治疗的非瓣膜性心房颤动（NVAF）患者的疗效与安全性。